Federal contract award
FA301623C0060
MEDICAL RESEARCH AND DEVELOPMENT - SBIR II TACFI
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | FA3016 502 CONS CL |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AJ12 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.8M |
| Current contract value | $1.8M |
| Potential contract value / ceiling | $1.8M |
| Start date | Sep 18, 2023 |
| Current end date | Sep 18, 2025 |
| Potential end date | Sep 18, 2025 |
| Latest award activity | Mar 14, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 14, 2025 | P00002 | $0 | TACTICAL FUNDING INCREASE (TACFI) FOR SBIR II CONTRACT FA864921P1557 TO DEVELOP PROTOTYPE DEVICES TO CONVERT THE SUBOPTIMAL MEDICATION ADMINISTRATION (SYRINGE AND MULTI-DOSE VIAL) TO AN AUTO-INJECTOR, ENABLING THE PAIN MEDICATION TO BE AVAILABLE FOR |
| Sep 21, 2023 | P00001 | $0 | MEDICAL RESEARCH AND DEVELOPMENT - SBIR II TACFI - AUTO-INJECTOR COMMERCIALIZATION |
| Sep 16, 2023 | 0 | $1.8M | MEDICAL RESEARCH AND DEVELOPMENT - SBIR II TACFI |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.